These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11530187)

  • 1. Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies.
    Horváth A; Andersen I; Junker K; Lyck Fogh-Schultz B; Holm Nielsen E; Gizurarson S; Andersen O; Kármán J; Rajnavölgyi E; Erdei A; Svehag SE
    Antiviral Res; 2001 Oct; 52(1):43-53. PubMed ID: 11530187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum amyloid P component binds to influenza A virus haemagglutinin and inhibits the virus infection in vitro.
    Andersen O; Vilsgaard Ravn K; Juul Sørensen I; Jonson G; Holm Nielsen E; Svehag SE
    Scand J Immunol; 1997 Oct; 46(4):331-7. PubMed ID: 9350282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses.
    Job ER; Bottazzi B; Gilbertson B; Edenborough KM; Brown LE; Mantovani A; Brooks AG; Reading PC
    PLoS One; 2013; 8(3):e59623. PubMed ID: 23544079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of the long chain pentraxin PTX3 against influenza viruses.
    Reading PC; Bozza S; Gilbertson B; Tate M; Moretti S; Job ER; Crouch EC; Brooks AG; Brown LE; Bottazzi B; Romani L; Mantovani A
    J Immunol; 2008 Mar; 180(5):3391-8. PubMed ID: 18292565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "Sho-seiryu-to"--effects on aged mice, against subtypes of a viruses and B virus, and therapeutic effect.
    Nagai T; Urata M; Yamada H
    Immunopharmacol Immunotoxicol; 1996 May; 18(2):193-208. PubMed ID: 8771367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo anti-influenza virus activity of kampo (Japanese herbal) medicine "sho-seiryu-to" and its mode of action.
    Nagai T; Yamada H
    Int J Immunopharmacol; 1994 Aug; 16(8):605-13. PubMed ID: 7527377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza virus infection is not affected by serum amyloid P component.
    Herbert J; Hutchinson WL; Carr J; Ives J; Jakob-Roetne R; Yamamura K; Suzuki M; Pepys MB
    Mol Med; 2002 Jan; 8(1):9-15. PubMed ID: 11984001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.
    Marjuki H; Mishin VP; Chai N; Tan MW; Newton EM; Tegeris J; Erlandson K; Willis M; Jones J; Davis T; Stevens J; Gubareva LV
    J Virol; 2016 Dec; 90(23):10446-10458. PubMed ID: 27630240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins.
    Anders EM; Hartley CA; Jackson DC
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4485-9. PubMed ID: 2162043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide.
    Kostolanský F; Mucha V; Slováková R; Varecková E
    Acta Virol; 2002; 46(4):229-36. PubMed ID: 12693859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel HA conformational change inhibitor of human influenza virus.
    Yoshimoto J; Kakui M; Iwasaki H; Fujiwara T; Sugimoto H; Hattori N
    Arch Virol; 1999; 144(5):865-78. PubMed ID: 10416371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin.
    Vanderlinden E; Göktas F; Cesur Z; Froeyen M; Reed ML; Russell CJ; Cesur N; Naesens L
    J Virol; 2010 May; 84(9):4277-88. PubMed ID: 20181685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of mice against lethal viral infection by synthetic peptides corresponding to B- and T-cell recognition sites of influenza A hemagglutinin.
    Simeckova-Rosenberg J; Yun Z; Wyde PR; Atassi MZ
    Vaccine; 1995 Jul; 13(10):927-32. PubMed ID: 7483766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of TheraMax on influenza virus infections in cell culture and in mice.
    Smee DF; Hurst BL; Wong MH
    Antivir Chem Chemother; 2011 Jul; 21(6):231-7. PubMed ID: 21730370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase.
    Yoshikawa T; Suzuki Y; Nomoto A; Sata T; Kurata T; Tamura Si
    Vaccine; 2002 Nov; 21(1-2):60-6. PubMed ID: 12443663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.
    Wohlbold TJ; Chromikova V; Tan GS; Meade P; Amanat F; Comella P; Hirsh A; Krammer F
    J Virol; 2016 Jan; 90(2):851-61. PubMed ID: 26512088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of conglutinin as an influenza A virus inhibitor.
    Wakamiya N; Okuno Y; Sasao F; Ueda S; Yoshimatsu K; Naiki M; Kurimura T
    Biochem Biophys Res Commun; 1992 Sep; 187(3):1270-8. PubMed ID: 1417803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y; Narayanan S; Chang KO
    Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PA Endonuclease Inhibitor RO-7 Protects Mice from Lethal Challenge with Influenza A or B Viruses.
    Jones JC; Marathe BM; Vogel P; Gasser R; Najera I; Govorkova EA
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.